Vick's Picks

Will Cell & Gene Therapies Break Insurance?

Bleeding edge clinical innovations need new commercial frameworks

Jul 31 • 

Vickram Pradhan

1

June 2025

Why Venture Math is Different for Family Offices

The intrinsic edge of evergreen capital

Jun 12 • 

Vickram Pradhan

3

March 2025

Segmenting Healthcare Innovation

Clinical, operational and commercial innovations offer distinct investment profiles

Mar 14 • 

Vickram Pradhan

2

February 2025

Mt. Rushmores (Part 2 - Executives)

Capitalist simping continued

Feb 23 • 

Vickram Pradhan

1

December 2024

Highly Recommended, 2024

It's a palooza of picks

Dec 31, 2024 • 

Vickram Pradhan

4

November 2024

Mt. Rushmores - Part 1 (Businesses)

Capitalist simping

Nov 27, 2024 • 

Vickram Pradhan

June 2024

Increasing Complexity in Biopharma Research

The clinical, operational and market complexity which plagues biopharma research is intensifying. Can technology help stakeholders navigate the chaos?

Jun 11, 2024 • 

Vickram Pradhan

2

January 2024

Mixed Reality in Healthcare

Exploring use cases in medical education and clinical training

Jan 25, 2024 • 

Vickram Pradhan

4

December 2023

The "Juniorization" of Healthcare

Stretching clinical supply to expand access

Dec 22, 2023 • 

Vickram Pradhan

3

2

August 2023

Macro Headwinds Cloud the Outlook for Healthtech Venture Capital

Worth less, but not worthless

Aug 13, 2023 • 

Vickram Pradhan

2

February 2023

Innovations in End-of-Life Care

Technology is changing how we die

Feb 16, 2023 • 

Vickram Pradhan

8

4

September 2022

Healthcare's Labor Challenges are Here to Stay

The era of chronic undersupply dawns. What does it mean for stakeholders?

Sep 16, 2022 • 

Vickram Pradhan

3